Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.
about
Enterovirus and type 1 diabetes: What is the matter?The streetlight effect in type 1 diabetesConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesComplement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Potential viral pathogenic mechanism in human type 1 diabetesA vision and a prescription for big data-enabled medicine.Practical aspects of gene regulatory inference via conditional inference forests from expression data.A Critical Role for the Type I Interferon Receptor in Virus-Induced Autoimmune Diabetes in Rats.A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Early prediction of autoimmune (type 1) diabetes.Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.Diabetes mellitus: The epidemic of the century.Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.Innate inflammation in type 1 diabetesPossible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR modelBlood-based signatures in type 1 diabetes.Rotavirus acceleration of type 1 diabetes in non-obese diabetic mice depends on type I interferon signallingType 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes.New Insights and Biomarkers for Type 1 Diabetes: Review for Scandinavian Journal of Immunology.Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression.Protective Role of Complement C3 Against Cytokine-Mediated β-Cell Apoptosis.A divergent population of autoantigen-responsive CD4+ T cells in infants prior to β cell autoimmunity.Early signs of disease in type 1 diabetes.Viruses in type 1 diabetes.Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.Longitudinal monitoring of gene expression in ultra-low-volume blood samples self-collected at home.Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells.Genome-wide gene expression profiling reveals that CD274 is up-regulated new-onset type 1 diabetes mellitus.Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes.Type I Interferon Is a Catastrophic Feature of the Diabetic Islet MicroenvironmentA preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signalingRedox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells.Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.
P2860
Q26830009-5FC46A06-B1CE-4B95-83FE-68978B99DB1AQ27023064-78B54E50-D94E-428C-9DC4-E7A09243E972Q28071490-99E1439D-8595-43EF-938C-AA2C55621918Q28601170-93897E31-52E3-4F90-8C53-043DA8AE3950Q28656023-013C94AC-85B4-4986-A50F-8D200CB2298AQ30937911-99981705-A7F8-486C-A918-43F516FD59EEQ31143693-093E11B4-C906-44C3-B2C4-6589B41A78A7Q31812554-96E04AED-C280-4060-8C54-8E95B1101E7CQ33789317-7368274D-A5AA-45F4-9C16-834913FE3FE3Q33854613-592BD293-F909-40E1-B774-8D54E54D238CQ34471099-82C285F8-893B-48A5-BB11-2191D729DE40Q34671155-DB5EAD02-F79C-442E-AC6D-3963315A5358Q35845445-FB721A2A-98AC-4FB1-9933-A4E93C72C5CFQ36039529-E3561D01-D4C6-44DD-8C0E-8340B61B0C40Q36225939-297EC601-95DB-476F-BDEB-AB98E31977BCQ36399376-AD525689-FBB1-4061-845D-B7BA6190C589Q36552481-5C7B26B1-DB6A-4DDE-BDF3-94F5A1AD77FBQ37089580-1DD4DC3B-5827-499E-9B83-DCE8E469D04EQ37098079-57B1F71C-D820-4DF4-AE52-F56291DF5515Q37619144-513DF0D7-9B46-4F2B-9B66-E2C3E7D2FF2BQ37659402-2B2FD8C8-FE3A-4146-804F-449E0B5FD463Q38385670-56911E8B-8EBC-4F97-8C8A-C9B0C3C61526Q38539481-25D89218-45F7-4A95-BA65-C7759AF22238Q38589318-3F65A5DC-4C1D-4D94-ADDF-013E70DB4CCCQ38743233-2E01E0F3-267C-4785-8650-9537864F6C77Q38754420-A6863B23-9169-43AF-9398-3C85F1D37AB4Q38895414-53D63478-DDC1-4E9A-803D-7876930BD686Q38895423-6D5A424C-AA4B-4B92-B357-3049F3D8F4C1Q38988559-0789823F-0551-401E-8E40-6C0E31C8BA6BQ39069291-25C51912-5111-4BCA-8139-6F9DAF4EA09AQ39405656-8DB8FE43-785F-4B3A-B7E0-B1D912818596Q39989398-A0C1833C-9927-4BCE-8474-6CE945EF7541Q40174575-90411346-16D5-41BF-A1E3-160B294F1A9DQ41460875-93F40C0A-D006-45B5-8B7D-5F7CDB359A74Q41672962-1BF6C719-3FAB-4ECF-90FD-74C32C3E672DQ41676983-66A0C41B-0FDB-4551-86D6-F7B189C44DEEQ42291845-FE77D765-B9DB-4F6D-A9A4-60EE7B70E212Q46284091-29CFE544-44A9-462B-ADE6-16CACF950AD8Q47228419-EE398CE6-AFD6-4271-A2E2-B63747650891Q47381290-6334111D-03EE-4B5A-8BBD-534C633C6D7F
P2860
Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@en
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@nl
type
label
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@en
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@nl
prefLabel
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@en
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@nl
P2093
P50
P356
P1433
P1476
Innate immune activity is dete ...... ype 1 diabetes susceptibility.
@en
P2093
Essi Laajala
Heikki Hyöty
Henna Kallionpää
Juha Mykkänen
Matti Vaarma
Olli Simell
Riitta Lahesmaa
Riitta Veijola
Tuula Simell
P304
P356
10.2337/DB13-1775
P407
P50
P577
2014-02-18T00:00:00Z